Retrospective study of thalidomide plus dexamethasone versus conventional chemotherapy in the relapsed multiple myeloma patient and the study of melphalan and prednisone versus melphalan, prednisone, and thalidomide. Hematology Meeting Reports, [S. l.], v. 1, n. 11, 2009. DOI: 10.4081/hmr.v1i11.351. Disponível em: https://journals.pagepress.org/hmr/article/view/351. Acesso em: 7 aug. 2025.